Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
about
Revolutionizing Alzheimer's disease and clinical trials through biomarkersDiagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysisTying malaria and microRNAs: from the biology to future diagnostic perspectivesThe MiRNA Journey from Theory to Practice as a CNS BiomarkerDiagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-AnalysisMethodological challenges in utilizing miRNAs as circulating biomarkersIncreased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.Circulating miRNAs profiles in Tourette syndrome: molecular data and clinical implications.WONOEP appraisal: new genetic approaches to study epilepsyUniversal disease biomarker: can a fixed set of blood microRNAs diagnose multiple diseases?The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?MicroRNA expression profiling in PBMCs: a potential diagnostic biomarker of chronic hepatitis CEditorial for "Regulatory RNAs in the nervous system".MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseasePlasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.MicroRNA‑34a induces apoptosis in PC12 cells by reducing B‑cell lymphoma 2 and sirtuin‑1 expression.MicroRNA based Pan-Cancer Diagnosis and Treatment RecommendationEffects of sample processing and storage on the integrity of cell-free miRNAs in maternal plasma.Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected PatientsAltered Striatocerebellar Metabolism and Systemic Inflammation in Parkinson's DiseaseKey genes expressed in different stages of spinal cord ischemia/reperfusion injury.Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma.Oncogenic micro-RNAs and Renal Cell Carcinoma.The potential of microRNAs as biofluid markers of neurodegenerative diseases--a systematic review.Circulating microRNA biomarkers for glioma and predicting response to therapy.MicroRNAs in brain metastases: potential role as diagnostics and therapeutics.miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650.Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening.Plasticity-related microRNA and their potential contribution to the maintenance of long-term potentiationEarly-Life Toxic Insults and Onset of Sporadic Neurodegenerative Diseases-an Overview of Experimental Studies.Current progress on microRNAs-based therapeutics in neurodegenerative diseases.An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.Optimal consistency in microRNA expression analysis using reference-gene-based normalization.Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.miRNA in Circulating Microvesicles as Biomarkers for Age-Related Cognitive Decline.Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).Multifactorial Origin of Neurodevelopmental Disorders: Approaches to Understanding Complex Etiologies.Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.
P2860
Q26744882-707A5033-A86B-4A9D-8EC1-022D76955FB2Q26748767-A81BA271-F06C-4D5C-9E04-3515DE5A9998Q26765405-0A7F716A-94E9-4775-90D4-1AE363ED4A89Q26767457-A312945D-151A-4E36-A138-4B82728A9E65Q26768181-EF994CF8-0B87-40BE-B921-06162548ACABQ27027950-9B151CCD-0902-417C-978D-1CBCF911FC9CQ30660817-AC9D1773-67BC-4D62-8FDB-B77E8CEA4452Q30982356-D7206F6F-6012-4718-905B-6BDA5EC23DA7Q34021111-AAD45DAF-6324-4788-B89D-DFA3B28BCAAAQ34168908-81B2AC45-8FEB-4E8F-A58B-99E485B7325FQ34426210-C1F4847D-528D-4E5A-B06C-6997F29F4E81Q34628003-E8E5B715-0C54-4534-859F-9D1E2C9E7CF9Q35067009-0165E26D-9F41-48D2-BBCB-C1C766B2248CQ35629123-E74E37E9-5E24-461F-8DB6-5A5407DDA40EQ35795155-6C01FDDD-3F42-4EF9-895F-654E3DB4B230Q36089892-C74151A8-68DC-43AE-867E-AA65464DE090Q36249115-90946886-AA9A-402F-9624-90BE1944038DQ36384651-CDC2D704-B3D8-4443-BCDF-5CC24CD957CDQ36594081-042D8A65-E569-4AB4-A78E-58D790621C9EQ37256739-4667FAD5-C84B-4A14-9FB5-658DC6E6A4B5Q37548384-060A63AD-3CA5-41BD-B7CC-A96472CE973CQ37549962-F4710865-E66E-432A-902C-69868D691CE5Q37640636-3D7BF664-255A-448D-8FE5-16ECCD78818DQ38200138-E1F0B505-14B7-4815-860A-B8E643C6079DQ38201683-2E91D96E-F12F-45DC-A77D-B986F3A10571Q38219675-9D810972-4A20-4542-AF61-F535B9475B61Q38259297-B4025711-587F-4D4F-9373-D1CFB0359D79Q38263664-CA5E178B-78E4-4542-B2C7-BF989EE5593CQ38371636-BB21A7F7-6E7A-4410-BC16-E96B04D029C6Q38676509-A2C0338E-7842-454C-8EB8-358E9C331868Q38791303-4E4F1DF0-93DD-4ED9-8490-8BAD731E7C04Q38887384-BBC96F2D-5766-4843-B79D-B1BDDC53FCECQ41181625-678432E0-4AD3-4F4B-BA03-2BDCEF2FCFA1Q41611297-F7903E57-60B6-4C20-BBE1-D3BBC61D14AFQ42372745-7B643A90-E8DE-44F5-B8A5-62302EE0925DQ42427048-F4848BAE-CEB7-4F83-B04F-0D7F02E3E6A1Q44429349-6B03E75A-E60A-4E94-BBDC-A3AA21CD973CQ45325968-D39FA3E8-DF8C-4700-A97C-DE49A171D1FEQ46830133-B3044AAC-8BEC-4ACC-8D5A-F6FB6AD62530Q47102033-BFEDCF96-BF2E-4AC0-AD48-E05B38F2AAFD
P2860
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating cell-free microRNA ...... d other neurologic pathologies
@en
Circulating cell-free microRNA ...... other neurologic pathologies.
@nl
type
label
Circulating cell-free microRNA ...... d other neurologic pathologies
@en
Circulating cell-free microRNA ...... other neurologic pathologies.
@nl
prefLabel
Circulating cell-free microRNA ...... d other neurologic pathologies
@en
Circulating cell-free microRNA ...... other neurologic pathologies.
@nl
P2860
P921
P356
P1476
Circulating cell-free microRNA ...... d other neurologic pathologies
@en
P2093
Kira S Sheinerman
Samuil R Umansky
P2860
P356
10.3389/FNCEL.2013.00150
P577
2013-09-10T00:00:00Z